Example: Heart Attack

Search clinical trials for: Fluoromisonidazole

Total 27 results

NCT00038038

Withdrawn

Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole

Conditions: Squamous Cell Carcinoma; Head and Neck Neoplasms; Metastases, Neoplasm
NCT00574353

Withdrawn

Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients

Conditions: Colorectal Cancer
NCT01898065

Completed

Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer

Conditions: Prostate Adenocarcinoma
NCT00606294

Active, not recruiting

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Conditions: Head and Neck Cancer
NCT01169350

Terminated

18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

Conditions: Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma
NCT00713037

Completed

Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas

Conditions: Chordoma
NCT03649880

Recruiting

Feasibility of FMISO in Brain Tumors

Conditions: Malignant Brain Neoplasm
NCT02695628

Completed

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Conditions: Adult Liver Carcinoma; Liver Cirrhosis
NCT03303469

Terminated

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

Conditions: Hepatocellular Carcinoma
NCT01246869

Recruiting

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Conditions: Brain Cancer
NCT00559377

Completed

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

Conditions: Cervical Adenocarcinoma; Cervical Squamous Cell Carcinoma; Stage IB Cervical Cancer; Stage IIA Cervical Cancer; Stage IIB Cervical Cancer; Stage III Cervical Cancer; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer
NCT01868906

Terminated

FMISO-PET in Brain Tumors and SCS Effect

Conditions: Malignant Glioma
NCT02061007

Withdrawn

Biomarker Correlates of Hypoxia in Metastatic Melanoma

Conditions: Melanoma; Skin Cancer
NCT00544674

Terminated

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Conditions: Lung Cancer
NCT03547388

Completed

Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment

Conditions: Head and Neck Neoplasms; Recurrence Tumor
NCT02841332

Terminated

Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma

Conditions: Glioblastoma
NCT02089204

Unknown status

Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma

Conditions: Nasopharyngeal Carcinoma
NCT00616213

Completed

PR104 and G-CSF in Treating Patients With Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
NCT00902577

Completed

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Conditions: Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma
NCT04309552

Not yet recruiting

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Conditions: Glioma
NCT03573986

Terminated

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Conditions: Recurrent Glioblastoma
NCT00906893

Completed

Evaluation of [18F]-FMISO for Non Operated Glioblastoma

Conditions: Glioblastoma
NCT01967927

Active, not recruiting

Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy

Conditions: Squamous Cell Carcinoma of the Head and Neck
NCT01235052

Completed

Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer

Conditions: Cancer of Head and Neck; Head and Neck Neoplasms
NCT02498613

Recruiting

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Conditions: Metastatic Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Stage III Breast Cancer AJCC v7; Stage III Lung Non-Small Cell Cancer AJCC v7; Stage III Lung Small Cell Carcinoma AJCC v7; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIA Lung Non-Small Cell Cancer AJCC v7; Stage IIIA Lung Small Cell Carcinoma AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIB Lung Non-Small Cell Cancer AJCC v7; Stage IIIB Lung Small Cell Carcinoma AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7; Stage IV Lung Non-Small Cell Cancer AJCC v7; Stage IV Lung Small Cell Carcinoma AJCC v7; Stage IV Pancreatic Cancer AJCC v6 and v7; Triple-Negative Breast Carcinoma; Unresectable Pancreatic Carcinoma